PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Guarino, C.* ; Hamon, Y. ; Croix, C.* ; Lamort, A.-S. ; Dallet-Choisy, S.* ; Marchand-Adam, S.* ; Lesner, A.* ; Baranek, T.* ; Viaud-Massuard, M.C.* ; Lauritzen, C.* ; Pedersen, J.H.* ; Heuze-Vourc'h, N.* ; Si-Tahar, M.* ; Firatli, E.* ; Jenne, D. ; Gauthier, F.* ; Horwitz, M.S.* ; Borregaard, N.* ; Korkmaz, B.*

Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.

Biochem. Pharmacol. 131, 52-67 (2017)
Postprint DOI PMC
Open Access Green
Cathepsin C (CatC) is a tetrameric cysteine dipeptidyl aminopeptidase that plays a key role in activation of pro-inflammatory serine protease zymogens by removal of a N-terminal pro-dipeptide sequence. Loss of function mutations in the CatC gene is associated with lack of immune cell serine protease activities and cause Papillon-Lefevre syndrome (PLS). Also, only very low levels of elastase-like protease zymogens are detected by proteome analysis of neutrophils from PLS patients. Thus, CatC inhibitors represent new alternatives for the treatment of neutrophil protease-driven inflammatory or autoimmune diseases. We aimed to experimentally inactivate and lower neutrophil elastase-like proteases by pharmacological blocking of CatC-dependent maturation in cell-based assays and in vivo. Isolated, immature bone marrow cells from healthy donors pulse-chased in the presence of a new cell permeable cyclopropyl nitrile CatC inhibitor almost totally lack elastase. We confirmed the elimination of neutrophil elastase-like proteases by prolonged inhibition of CatC in a non-human primate. We also showed that neutrophils lacking elastase-like protease activities were still recruited to inflammatory sites. These preclinical results demonstrate that the disappearance of neutrophil elastase-like proteases as observed in PLS patients can be achieved by pharmacological inhibition of bone marrow CatC. Such a transitory inhibition of CatC might thus help to rebalance the protease load during chronic inflammatory diseases, which opens new perspectives for therapeutic applications in humans.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.581
0.000
24
25
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cathepsin C ; Neutrophil ; Serine Protease ; Cysteine Protease ; Inhibitor ; Papillon-lefevre Syndrome; Dipeptidyl-peptidase-i; Papillon-lefevre-syndrome; Human-diseases; Proteinase-3; Elastase; Substrate; Requires; Granules; Gene; Vivo
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 0006-2952
e-ISSN 0006-2952
Zeitschrift Biochemical Pharmacology
Quellenangaben Band: 131, Heft: , Seiten: 52-67 Artikelnummer: , Supplement: ,
Verlag Elsevier
Verlagsort Oxford
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Lung Research
PSP-Element(e) G-501600-005
DOI 10.1016/j.bcp.2017.02.009
WOS ID WOS:000399256700005
Scopus ID 85014067795
PubMed ID 28193451
Erfassungsdatum 2017-06-21
[➜Korrektur melden]